This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Jeung Whan Han: Innovator in Anti-Tumor Compositions
Introduction
Jeung Whan Han is a notable inventor based in Kyunggi-do Suwon-si, South Korea. He has made significant contributions to the field of anti-tumor research through his innovative work on apicidin derivatives. His research focuses on developing compounds that can effectively inhibit cancer cell growth.
Latest Patents
Jeung Whan Han holds a patent for "Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them." This patent describes a substituted apicidin derivative, along with its synthesis method and an anti-tumor composition that includes the derivative. The substituents of the derivative include various hydrazones and sulfonylhydrazones, which have shown strong inhibition effects against histone deacetylase and the ability to specifically inhibit the growth of cancer cells. This makes his invention particularly valuable in the preparation of anti-tumor compositions.
Career Highlights
Throughout his career, Jeung Whan Han has focused on the synthesis of compounds that can combat cancer. His work has led to advancements in the understanding of how certain derivatives can be utilized in medical applications. His dedication to research and innovation has positioned him as a key figure in the field of anti-cancer therapies.
Collaborations
Jeung Whan Han has collaborated with notable colleagues such as Hyang Woo Lee and Young Hoon Jung. These collaborations have contributed to the development of his patented inventions and have enhanced the research efforts in the field of anti-tumor compositions.
Conclusion
Jeung Whan Han's contributions to the field of anti-tumor research through his innovative patents highlight the importance of continued research in cancer therapies. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile